ABT Molecular Imaging, Inc.


Our

NEWS

Professor Bengt Langstrom joins ABT Board of Directors

Knoxville, Tennessee, January 23, 2012 - ABT Molecular Imaging, Inc. a molecular imaging company and manufacturer of the “Dose on Demand” Biomarker Generator which provides researchers and clinicians access to PET biomarkers on demand, today announced the appointment of Professor Bengt Langstrom to its Board of Directors.
Read More>>

'First in Europe' Cancer Equipment Delivered to Newcastle

A cutting-edge piece of cancer treatment and research equipment purchased through a record £625,000 contribution from the Sir Bobby Robson Foundation is being installed this week in Newcastle upon Tyne. The ultra-compact ABT Molecular Imaging Biomarker Generator is only the second of its type in the world and the first in Europe and will help with the diagnosis and treatment of cancer and other serious diseases...
Read More>>

ABT ships first Biomarker Generator in Europe to Newcastle University

ABT Molecular Imaging, Inc. a molecular imaging company and manufacturer of the "Dose on Demand" Biomarker Generator which provides researchers and clinicians access to PET biomarkers on demand, shipped the first system...
Read More>>

ABT Molecular Imaging Names New Radiochemist and New Director of Technical Services

ABT Molecular Imaging, a medical imaging company and manufacturer of the "Dose on Demand" Biomarker Generator for unit dose production of biomarkers for Molecular Imaging, announced today that Dr. Atilio Anzellotti has joined the company as Senior Radio-chemist, and Mr. Steve Torres has joined the company as the Senior Director of Technical Services.
Read More>>

OU college pioneers biomarker generator

The OU College of Pharmacy will be the first institution in the world to install and use a biomarker generator for help in imaging and diagnosing diseases. A biomarker generator creates a radiation tag doctors can look for in scans of the body to identify substances, such as cancerous tumors or brain plaques associated with Alzheimer’s disease, said Vibhudutta Awasthi, College of Pharmacy researcher and professor.
POSTED BY Kathleen Evans/The Daily @ oudaily.com
Read More>>